nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—UGT1A4—Tamoxifen—pancreatic cancer	0.259	0.311	CbGbCtD
Midazolam—CYP2E1—Dacarbazine—pancreatic cancer	0.0421	0.0506	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0347	0.0417	CbGbCtD
Midazolam—CYP3A7—Tamoxifen—pancreatic cancer	0.0347	0.0417	CbGbCtD
Midazolam—CYP2E1—Tamoxifen—pancreatic cancer	0.0335	0.0402	CbGbCtD
Midazolam—CYP2B6—Tamoxifen—pancreatic cancer	0.033	0.0397	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0266	0.032	CbGbCtD
Midazolam—CYP3A7—Irinotecan—pancreatic cancer	0.0266	0.032	CbGbCtD
Midazolam—CYP3A5—Tamoxifen—pancreatic cancer	0.026	0.0313	CbGbCtD
Midazolam—CYP2B6—Irinotecan—pancreatic cancer	0.0254	0.0305	CbGbCtD
Midazolam—CYP3A5—Erlotinib—pancreatic cancer	0.0221	0.0266	CbGbCtD
Midazolam—CYP3A5—Irinotecan—pancreatic cancer	0.02	0.024	CbGbCtD
Midazolam—CYP3A7—Docetaxel—pancreatic cancer	0.0195	0.0235	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0195	0.0235	CbGbCtD
Midazolam—CYP3A7—Sunitinib—pancreatic cancer	0.0194	0.0234	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0194	0.0234	CbGbCtD
Midazolam—ABCB1—Tamoxifen—pancreatic cancer	0.0169	0.0204	CbGbCtD
Midazolam—CYP3A5—Docetaxel—pancreatic cancer	0.0146	0.0176	CbGbCtD
Midazolam—ABCB1—Gemcitabine—pancreatic cancer	0.0146	0.0175	CbGbCtD
Midazolam—CYP3A5—Sunitinib—pancreatic cancer	0.0146	0.0175	CbGbCtD
Midazolam—ABCB1—Erlotinib—pancreatic cancer	0.0144	0.0173	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—pancreatic cancer	0.0139	0.0167	CbGbCtD
Midazolam—ABCB1—Irinotecan—pancreatic cancer	0.013	0.0156	CbGbCtD
Midazolam—CYP3A4—Tamoxifen—pancreatic cancer	0.0101	0.0122	CbGbCtD
Midazolam—ABCB1—Docetaxel—pancreatic cancer	0.00953	0.0115	CbGbCtD
Midazolam—ABCB1—Sunitinib—pancreatic cancer	0.00949	0.0114	CbGbCtD
Midazolam—CYP3A4—Erlotinib—pancreatic cancer	0.00863	0.0104	CbGbCtD
Midazolam—CYP3A4—Irinotecan—pancreatic cancer	0.00779	0.00936	CbGbCtD
Midazolam—ABCB1—Doxorubicin—pancreatic cancer	0.00711	0.00854	CbGbCtD
Midazolam—CYP3A4—Docetaxel—pancreatic cancer	0.00571	0.00686	CbGbCtD
Midazolam—CYP3A4—Sunitinib—pancreatic cancer	0.00568	0.00683	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—pancreatic cancer	0.00426	0.00512	CbGbCtD
Midazolam—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000289	0.00172	CcSEcCtD
Midazolam—Cough—Gemcitabine—pancreatic cancer	0.000288	0.00172	CcSEcCtD
Midazolam—Pain—Sunitinib—pancreatic cancer	0.000287	0.00171	CcSEcCtD
Midazolam—Constipation—Sunitinib—pancreatic cancer	0.000287	0.00171	CcSEcCtD
Midazolam—Phlebitis—Doxorubicin—pancreatic cancer	0.000282	0.00168	CcSEcCtD
Midazolam—Asthenia—Tamoxifen—pancreatic cancer	0.000281	0.00168	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00028	0.00167	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000279	0.00166	CcSEcCtD
Midazolam—Confusional state—Irinotecan—pancreatic cancer	0.000279	0.00166	CcSEcCtD
Midazolam—Asthenia—Erlotinib—pancreatic cancer	0.000278	0.00166	CcSEcCtD
Midazolam—Pruritus—Tamoxifen—pancreatic cancer	0.000277	0.00165	CcSEcCtD
Midazolam—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000277	0.00165	CcSEcCtD
Midazolam—Pruritus—Erlotinib—pancreatic cancer	0.000274	0.00164	CcSEcCtD
Midazolam—Shock—Irinotecan—pancreatic cancer	0.000272	0.00162	CcSEcCtD
Midazolam—Nervous system disorder—Irinotecan—pancreatic cancer	0.000271	0.00162	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000271	0.00162	CcSEcCtD
Midazolam—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000269	0.00161	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—pancreatic cancer	0.000269	0.0016	CcSEcCtD
Midazolam—Lethargy—Epirubicin—pancreatic cancer	0.000268	0.0016	CcSEcCtD
Midazolam—Confusional state—Fluorouracil—pancreatic cancer	0.000267	0.00159	CcSEcCtD
Midazolam—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000265	0.00158	CcSEcCtD
Midazolam—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000264	0.00158	CcSEcCtD
Midazolam—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000264	0.00157	CcSEcCtD
Midazolam—Diplopia—Epirubicin—pancreatic cancer	0.000262	0.00156	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—pancreatic cancer	0.000262	0.00156	CcSEcCtD
Midazolam—Skin disorder—Gemcitabine—pancreatic cancer	0.000262	0.00156	CcSEcCtD
Midazolam—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00026	0.00155	CcSEcCtD
Midazolam—Visual impairment—Docetaxel—pancreatic cancer	0.000259	0.00155	CcSEcCtD
Midazolam—Dizziness—Tamoxifen—pancreatic cancer	0.000259	0.00154	CcSEcCtD
Midazolam—Tachycardia—Fluorouracil—pancreatic cancer	0.000258	0.00154	CcSEcCtD
Midazolam—Hypotension—Irinotecan—pancreatic cancer	0.000258	0.00154	CcSEcCtD
Midazolam—Affect lability—Epirubicin—pancreatic cancer	0.000258	0.00154	CcSEcCtD
Midazolam—Dizziness—Erlotinib—pancreatic cancer	0.000256	0.00153	CcSEcCtD
Midazolam—Hypotension—Gemcitabine—pancreatic cancer	0.000252	0.0015	CcSEcCtD
Midazolam—Eye disorder—Docetaxel—pancreatic cancer	0.000251	0.0015	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000251	0.00149	CcSEcCtD
Midazolam—Cardiac disorder—Docetaxel—pancreatic cancer	0.00025	0.00149	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—pancreatic cancer	0.000249	0.00149	CcSEcCtD
Midazolam—Vomiting—Tamoxifen—pancreatic cancer	0.000249	0.00149	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—pancreatic cancer	0.000249	0.00148	CcSEcCtD
Midazolam—Mood swings—Epirubicin—pancreatic cancer	0.000249	0.00148	CcSEcCtD
Midazolam—Paraesthesia—Irinotecan—pancreatic cancer	0.000248	0.00148	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—pancreatic cancer	0.000248	0.00148	CcSEcCtD
Midazolam—Hypotension—Fluorouracil—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Hypersensitivity—Sunitinib—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Rash—Tamoxifen—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Dermatitis—Tamoxifen—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Ataxia—Epirubicin—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Vomiting—Erlotinib—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Dyspnoea—Irinotecan—pancreatic cancer	0.000247	0.00147	CcSEcCtD
Midazolam—Somnolence—Irinotecan—pancreatic cancer	0.000246	0.00147	CcSEcCtD
Midazolam—Headache—Tamoxifen—pancreatic cancer	0.000246	0.00146	CcSEcCtD
Midazolam—Rash—Erlotinib—pancreatic cancer	0.000245	0.00146	CcSEcCtD
Midazolam—Dermatitis—Erlotinib—pancreatic cancer	0.000244	0.00146	CcSEcCtD
Midazolam—Dyspepsia—Irinotecan—pancreatic cancer	0.000243	0.00145	CcSEcCtD
Midazolam—Immune system disorder—Docetaxel—pancreatic cancer	0.000243	0.00145	CcSEcCtD
Midazolam—Headache—Erlotinib—pancreatic cancer	0.000243	0.00145	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—pancreatic cancer	0.000243	0.00145	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000243	0.00145	CcSEcCtD
Midazolam—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000242	0.00145	CcSEcCtD
Midazolam—Paraesthesia—Gemcitabine—pancreatic cancer	0.000242	0.00144	CcSEcCtD
Midazolam—Chills—Docetaxel—pancreatic cancer	0.000241	0.00144	CcSEcCtD
Midazolam—Asthenia—Sunitinib—pancreatic cancer	0.000241	0.00144	CcSEcCtD
Midazolam—Dyspnoea—Gemcitabine—pancreatic cancer	0.00024	0.00143	CcSEcCtD
Midazolam—Somnolence—Gemcitabine—pancreatic cancer	0.000239	0.00143	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—pancreatic cancer	0.000239	0.00142	CcSEcCtD
Midazolam—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000239	0.00142	CcSEcCtD
Midazolam—Fatigue—Irinotecan—pancreatic cancer	0.000238	0.00142	CcSEcCtD
Midazolam—Paraesthesia—Fluorouracil—pancreatic cancer	0.000238	0.00142	CcSEcCtD
Midazolam—Pruritus—Sunitinib—pancreatic cancer	0.000238	0.00142	CcSEcCtD
Midazolam—Constipation—Irinotecan—pancreatic cancer	0.000236	0.00141	CcSEcCtD
Midazolam—Pain—Irinotecan—pancreatic cancer	0.000236	0.00141	CcSEcCtD
Midazolam—Dyspnoea—Fluorouracil—pancreatic cancer	0.000236	0.00141	CcSEcCtD
Midazolam—Mental disorder—Docetaxel—pancreatic cancer	0.000236	0.0014	CcSEcCtD
Midazolam—Somnolence—Fluorouracil—pancreatic cancer	0.000235	0.0014	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000235	0.0014	CcSEcCtD
Midazolam—Erythema—Docetaxel—pancreatic cancer	0.000234	0.0014	CcSEcCtD
Midazolam—Dyspepsia—Fluorouracil—pancreatic cancer	0.000233	0.00139	CcSEcCtD
Midazolam—Nausea—Tamoxifen—pancreatic cancer	0.000233	0.00139	CcSEcCtD
Midazolam—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000233	0.00139	CcSEcCtD
Midazolam—Fatigue—Gemcitabine—pancreatic cancer	0.000232	0.00138	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—pancreatic cancer	0.000231	0.00138	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000231	0.00138	CcSEcCtD
Midazolam—Constipation—Gemcitabine—pancreatic cancer	0.00023	0.00137	CcSEcCtD
Midazolam—Pain—Gemcitabine—pancreatic cancer	0.00023	0.00137	CcSEcCtD
Midazolam—Nausea—Erlotinib—pancreatic cancer	0.00023	0.00137	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—pancreatic cancer	0.00023	0.00137	CcSEcCtD
Midazolam—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000229	0.00136	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—pancreatic cancer	0.000228	0.00136	CcSEcCtD
Midazolam—Feeling abnormal—Irinotecan—pancreatic cancer	0.000228	0.00136	CcSEcCtD
Midazolam—Pain—Fluorouracil—pancreatic cancer	0.000226	0.00135	CcSEcCtD
Midazolam—Dizziness—Sunitinib—pancreatic cancer	0.000222	0.00132	CcSEcCtD
Midazolam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000222	0.00132	CcSEcCtD
Midazolam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000218	0.0013	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000217	0.00129	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—pancreatic cancer	0.000214	0.00128	CcSEcCtD
Midazolam—Vomiting—Sunitinib—pancreatic cancer	0.000213	0.00127	CcSEcCtD
Midazolam—Rash—Sunitinib—pancreatic cancer	0.000212	0.00126	CcSEcCtD
Midazolam—Dermatitis—Sunitinib—pancreatic cancer	0.000211	0.00126	CcSEcCtD
Midazolam—Urticaria—Fluorouracil—pancreatic cancer	0.00021	0.00125	CcSEcCtD
Midazolam—Headache—Sunitinib—pancreatic cancer	0.00021	0.00125	CcSEcCtD
Midazolam—Syncope—Docetaxel—pancreatic cancer	0.00021	0.00125	CcSEcCtD
Midazolam—Cough—Docetaxel—pancreatic cancer	0.000204	0.00122	CcSEcCtD
Midazolam—Hypersensitivity—Irinotecan—pancreatic cancer	0.000204	0.00121	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—pancreatic cancer	0.000202	0.0012	CcSEcCtD
Midazolam—Nausea—Sunitinib—pancreatic cancer	0.000199	0.00119	CcSEcCtD
Midazolam—Asthenia—Irinotecan—pancreatic cancer	0.000198	0.00118	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000198	0.00118	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000198	0.00118	CcSEcCtD
Midazolam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000195	0.00116	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—pancreatic cancer	0.000195	0.00116	CcSEcCtD
Midazolam—Asthenia—Gemcitabine—pancreatic cancer	0.000193	0.00115	CcSEcCtD
Midazolam—Confusional state—Docetaxel—pancreatic cancer	0.000193	0.00115	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000191	0.00114	CcSEcCtD
Midazolam—Pruritus—Gemcitabine—pancreatic cancer	0.000191	0.00114	CcSEcCtD
Midazolam—Shock—Docetaxel—pancreatic cancer	0.000188	0.00112	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—pancreatic cancer	0.000187	0.00112	CcSEcCtD
Midazolam—Pruritus—Fluorouracil—pancreatic cancer	0.000187	0.00112	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—pancreatic cancer	0.000187	0.00111	CcSEcCtD
Midazolam—Tachycardia—Docetaxel—pancreatic cancer	0.000187	0.00111	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—pancreatic cancer	0.000186	0.00111	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—pancreatic cancer	0.000185	0.0011	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000183	0.00109	CcSEcCtD
Midazolam—Dizziness—Irinotecan—pancreatic cancer	0.000183	0.00109	CcSEcCtD
Midazolam—Hypotension—Docetaxel—pancreatic cancer	0.000179	0.00106	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000178	0.00106	CcSEcCtD
Midazolam—Vomiting—Irinotecan—pancreatic cancer	0.000176	0.00105	CcSEcCtD
Midazolam—Dizziness—Fluorouracil—pancreatic cancer	0.000175	0.00104	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—pancreatic cancer	0.000175	0.00104	CcSEcCtD
Midazolam—Rash—Irinotecan—pancreatic cancer	0.000174	0.00104	CcSEcCtD
Midazolam—Dermatitis—Irinotecan—pancreatic cancer	0.000174	0.00104	CcSEcCtD
Midazolam—Headache—Irinotecan—pancreatic cancer	0.000173	0.00103	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—pancreatic cancer	0.000172	0.00102	CcSEcCtD
Midazolam—Vomiting—Gemcitabine—pancreatic cancer	0.000171	0.00102	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—pancreatic cancer	0.000171	0.00102	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—pancreatic cancer	0.00017	0.00102	CcSEcCtD
Midazolam—Somnolence—Docetaxel—pancreatic cancer	0.00017	0.00101	CcSEcCtD
Midazolam—Rash—Gemcitabine—pancreatic cancer	0.00017	0.00101	CcSEcCtD
Midazolam—Dermatitis—Gemcitabine—pancreatic cancer	0.00017	0.00101	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—pancreatic cancer	0.00017	0.00101	CcSEcCtD
Midazolam—Headache—Gemcitabine—pancreatic cancer	0.000169	0.00101	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—pancreatic cancer	0.000168	0.001	CcSEcCtD
Midazolam—Vomiting—Fluorouracil—pancreatic cancer	0.000168	0.001	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—pancreatic cancer	0.000168	0.001	CcSEcCtD
Midazolam—Rash—Fluorouracil—pancreatic cancer	0.000167	0.000995	CcSEcCtD
Midazolam—Dermatitis—Fluorouracil—pancreatic cancer	0.000167	0.000994	CcSEcCtD
Midazolam—Headache—Fluorouracil—pancreatic cancer	0.000166	0.000989	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000165	0.000984	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000165	0.000983	CcSEcCtD
Midazolam—Fatigue—Docetaxel—pancreatic cancer	0.000165	0.000982	CcSEcCtD
Midazolam—Nausea—Irinotecan—pancreatic cancer	0.000164	0.000979	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—pancreatic cancer	0.000164	0.000977	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000164	0.000975	CcSEcCtD
Midazolam—Pain—Docetaxel—pancreatic cancer	0.000163	0.000974	CcSEcCtD
Midazolam—Constipation—Docetaxel—pancreatic cancer	0.000163	0.000974	CcSEcCtD
Midazolam—Chills—Epirubicin—pancreatic cancer	0.000163	0.00097	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—pancreatic cancer	0.000162	0.000964	CcSEcCtD
Midazolam—Nausea—Gemcitabine—pancreatic cancer	0.00016	0.000954	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—pancreatic cancer	0.000159	0.000948	CcSEcCtD
Midazolam—Erythema—Epirubicin—pancreatic cancer	0.000158	0.000942	CcSEcCtD
Midazolam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000158	0.000939	CcSEcCtD
Midazolam—Nausea—Fluorouracil—pancreatic cancer	0.000157	0.000938	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—pancreatic cancer	0.000157	0.000935	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000156	0.000929	CcSEcCtD
Midazolam—Tension—Epirubicin—pancreatic cancer	0.000155	0.000924	CcSEcCtD
Midazolam—Nervousness—Epirubicin—pancreatic cancer	0.000153	0.000914	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—pancreatic cancer	0.000152	0.000904	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000151	0.000902	CcSEcCtD
Midazolam—Chills—Doxorubicin—pancreatic cancer	0.000151	0.000898	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—pancreatic cancer	0.000149	0.000887	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—pancreatic cancer	0.000147	0.000877	CcSEcCtD
Midazolam—Erythema—Doxorubicin—pancreatic cancer	0.000146	0.000871	CcSEcCtD
Midazolam—Agitation—Epirubicin—pancreatic cancer	0.000145	0.000865	CcSEcCtD
Midazolam—Tension—Doxorubicin—pancreatic cancer	0.000143	0.000855	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—pancreatic cancer	0.000142	0.000846	CcSEcCtD
Midazolam—Vertigo—Epirubicin—pancreatic cancer	0.000142	0.000846	CcSEcCtD
Midazolam—Syncope—Epirubicin—pancreatic cancer	0.000142	0.000844	CcSEcCtD
Midazolam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000141	0.000839	CcSEcCtD
Midazolam—Cough—Epirubicin—pancreatic cancer	0.000138	0.000822	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—pancreatic cancer	0.000138	0.000821	CcSEcCtD
Midazolam—Asthenia—Docetaxel—pancreatic cancer	0.000137	0.000817	CcSEcCtD
Midazolam—Pruritus—Docetaxel—pancreatic cancer	0.000135	0.000806	CcSEcCtD
Midazolam—Agitation—Doxorubicin—pancreatic cancer	0.000134	0.000801	CcSEcCtD
Midazolam—Anxiety—Epirubicin—pancreatic cancer	0.000134	0.000799	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000134	0.000796	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—pancreatic cancer	0.000132	0.000784	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—pancreatic cancer	0.000131	0.000783	CcSEcCtD
Midazolam—Syncope—Doxorubicin—pancreatic cancer	0.000131	0.000781	CcSEcCtD
Midazolam—Confusional state—Epirubicin—pancreatic cancer	0.00013	0.000775	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000129	0.000768	CcSEcCtD
Midazolam—Cough—Doxorubicin—pancreatic cancer	0.000128	0.00076	CcSEcCtD
Midazolam—Shock—Epirubicin—pancreatic cancer	0.000127	0.000756	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—pancreatic cancer	0.000126	0.000754	CcSEcCtD
Midazolam—Dizziness—Docetaxel—pancreatic cancer	0.000126	0.000753	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—pancreatic cancer	0.000126	0.00075	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—pancreatic cancer	0.000125	0.000746	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—pancreatic cancer	0.000124	0.000739	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000124	0.000737	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—pancreatic cancer	0.000122	0.000725	CcSEcCtD
Midazolam—Vomiting—Docetaxel—pancreatic cancer	0.000122	0.000724	CcSEcCtD
Midazolam—Rash—Docetaxel—pancreatic cancer	0.000121	0.000718	CcSEcCtD
Midazolam—Hypotension—Epirubicin—pancreatic cancer	0.00012	0.000718	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—pancreatic cancer	0.00012	0.000718	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—pancreatic cancer	0.00012	0.000717	CcSEcCtD
Midazolam—Headache—Docetaxel—pancreatic cancer	0.00012	0.000714	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000119	0.000711	CcSEcCtD
Midazolam—Shock—Doxorubicin—pancreatic cancer	0.000117	0.0007	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000117	0.000697	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—pancreatic cancer	0.000116	0.000694	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—pancreatic cancer	0.000116	0.000691	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—pancreatic cancer	0.000116	0.00069	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—pancreatic cancer	0.000115	0.000685	CcSEcCtD
Midazolam—Somnolence—Epirubicin—pancreatic cancer	0.000115	0.000683	CcSEcCtD
Midazolam—Nausea—Docetaxel—pancreatic cancer	0.000114	0.000677	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—pancreatic cancer	0.000113	0.000676	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—pancreatic cancer	0.000111	0.000664	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000111	0.000663	CcSEcCtD
Midazolam—Fatigue—Epirubicin—pancreatic cancer	0.000111	0.000662	CcSEcCtD
Midazolam—Pain—Epirubicin—pancreatic cancer	0.00011	0.000657	CcSEcCtD
Midazolam—Constipation—Epirubicin—pancreatic cancer	0.00011	0.000657	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—pancreatic cancer	0.000107	0.000638	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—pancreatic cancer	0.000106	0.000634	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000106	0.000633	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—pancreatic cancer	0.000106	0.000632	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—pancreatic cancer	0.000105	0.000626	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000103	0.000614	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—pancreatic cancer	0.000103	0.000613	CcSEcCtD
Midazolam—Urticaria—Epirubicin—pancreatic cancer	0.000102	0.00061	CcSEcCtD
Midazolam—Constipation—Doxorubicin—pancreatic cancer	0.000102	0.000608	CcSEcCtD
Midazolam—Pain—Doxorubicin—pancreatic cancer	0.000102	0.000608	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—pancreatic cancer	9.83e-05	0.000586	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—pancreatic cancer	9.5e-05	0.000566	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—pancreatic cancer	9.48e-05	0.000565	CcSEcCtD
Midazolam—Asthenia—Epirubicin—pancreatic cancer	9.25e-05	0.000551	CcSEcCtD
Midazolam—Pruritus—Epirubicin—pancreatic cancer	9.12e-05	0.000544	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—pancreatic cancer	8.79e-05	0.000524	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—pancreatic cancer	8.56e-05	0.00051	CcSEcCtD
Midazolam—Dizziness—Epirubicin—pancreatic cancer	8.53e-05	0.000508	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—pancreatic cancer	8.44e-05	0.000503	CcSEcCtD
Midazolam—Vomiting—Epirubicin—pancreatic cancer	8.2e-05	0.000489	CcSEcCtD
Midazolam—Rash—Epirubicin—pancreatic cancer	8.13e-05	0.000485	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—pancreatic cancer	8.12e-05	0.000484	CcSEcCtD
Midazolam—Headache—Epirubicin—pancreatic cancer	8.08e-05	0.000481	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—pancreatic cancer	7.89e-05	0.00047	CcSEcCtD
Midazolam—Nausea—Epirubicin—pancreatic cancer	7.66e-05	0.000456	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—pancreatic cancer	7.59e-05	0.000452	CcSEcCtD
Midazolam—Rash—Doxorubicin—pancreatic cancer	7.52e-05	0.000448	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000448	CcSEcCtD
Midazolam—Headache—Doxorubicin—pancreatic cancer	7.47e-05	0.000445	CcSEcCtD
Midazolam—Nausea—Doxorubicin—pancreatic cancer	7.09e-05	0.000422	CcSEcCtD
